Testing a mosquito-repelling device to prevent malaria in kids
Part of Infections clinical trials.
This trial is testing a special device that releases a scent to repel mosquitoes, aiming to reduce malaria in young children in Uganda. If you have a child under 5 and are willing to use the device in your home, this study could help protect your child from malaria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a child 5 years old or younger living in your home.
- You agree to use the study device in your home and allow research visits.
- Your child sleeps at home almost every night (at least 9 out of 10 nights per month).
- Your child does not plan to travel away from home for more than one month during the study.
- Your child is not taking daily or weekly malaria prevention medicine.
- Your child is not in any other clinical trial for a vaccine, drug, or device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a mosquito repellent that is placed in homes to see if it helps prevent malaria. It is for children living in the area.
This study looks at how malaria spreads in Mozambique by testing children and pregnant women with fever. If you or your child may have malaria, participating could help researchers understand and fight the disease better.
This study tests a new long-acting malaria prevention injection (MMV371) in healthy adults and adolescents in Rwanda. Researchers will monitor how safe it is and how your body processes it over 24 weeks.
This study looks at whether adding a special device (the Guardian Spatial Emanator) to the AZVINIR II azithromycin program helps prevent malaria. It involves checking households and health centers in high-malaria areas in Africa.
This study tests a new pill called lotilaner for safety and how well it works to kill mosquitoes that carry malaria. It is for healthy adults in Mali and may help future malaria prevention efforts.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.